Stock EBAC EURO BIOT
Add to a list
To use this feature you must be a member
Log inSign up

EURO BIOT

Equities

EBAC

KYG3167F1028

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
12.02 USD +0.59% Intraday chart for EURO BIOT +1.44% +7.42%
2023 European Biotech Acquisition Corp.(NasdaqCM:EBAC) dropped from NASDAQ Composite Index CI
2023 Oculis SA completed the acquition of European Biotech Acquisition Corp. from Lsp Sponsor Ebac B.V. and others in a reverse merger. CI

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration

Latest news about EURO BIOT

European Biotech Acquisition Corp.(NasdaqCM:EBAC) dropped from NASDAQ Composite Index CI
Oculis SA completed the acquition of European Biotech Acquisition Corp. from Lsp Sponsor Ebac B.V. and others in a reverse merger. CI
European Biotech Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
European Biotech Acquisition Corp. Auditor Raises 'Going Concern' Doubt CI
European Biotech Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
European Biotech Acquisition, Oculis Strike Merger Agreement MT
Oculis SA entered into a Business Combination Agreement to acquire European Biotech Acquisition Corp. from Lsp Sponsor Ebac B.V. in a reverse merger for approximately $210 million. CI
European Biotech Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
European Biotech Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
European Biotech Acquisition Corp. Auditor Raises 'Going Concern' Doubt CI
Certain Class B Ordinary Shares of European Biotech Acquisition Corp. are subject to a Lock-Up Agreement Ending on 15-SEP-2021. CI
European Biotech Acquisition Corp.(NasdaqCM:EBAC) added to NASDAQ Composite Index CI
European Biotech Acquisition Corp. announced that it has received $4.55096 million in funding from Lsp Sponsor Ebac B.V. CI
European Biotech Acquisition Corp. Appoints Mohammad Sohail Fazeli to the Board CI
European Biotech Acquisition Corp. has completed an IPO in the amount of $120 million. CI
European Biotech Acquisition Corp. has filed an IPO in the amount of $100 million. CI
European Biotech Acquisition Corp. announced that it expects to receive $4 million in funding from Lsp Sponsor Ebac B.V. CI

Chart EURO BIOT

Chart EURO BIOT
More charts

Company Profile

European Biotech Acquisition Corp is a blanc check company based in the Netherlands. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The Company intends to primarily seek to identify a company within the European life sciences industry. The aim of the Company is investments in therapeutic drug candidates in clinical development across a range of therapeutic areas, including oncology, diabetes, cardiology, central nervous system (CNS) and orphan diseases.
Sector
-
More about the company

Income Statement Evolution

More financial data
  1. Stock Market
  2. Equities
  3. EBAC Stock
  4. News EURO BIOT
  5. European Biotech Acquisition, Oculis Strike Merger Agreement